Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
wolf-screen-ratio-mammosphere-adherent | 0.967 | 8.73e-17 | 1.20e-03 | 2.36e-02 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
[ TNF ] | 7124 | 1 | 0.021 | 0.967 | 98 | - | - |
RBX1 | 9978 | 97 | 1.185 | 1.151 | 139 | Yes | - |
RPL8 | 6132 | 9 | 0.778 | 0.967 | 218 | Yes | - |
PSMB7 | 5695 | 48 | 0.982 | 1.052 | 57 | Yes | - |
PSMA1 | 5682 | 61 | 0.996 | 1.052 | 123 | Yes | - |
ATP6V1B2 | 526 | 44 | 0.881 | 1.076 | 278 | - | - |
RPSA | 3921 | 156 | 1.327 | 1.151 | 152 | Yes | - |
RPA2 | 6118 | 98 | 1.250 | 1.151 | 69 | Yes | - |
CDC16 | 8881 | 25 | 0.950 | 1.020 | 80 | Yes | - |
EEF2 | 1938 | 27 | 0.890 | 1.043 | 301 | Yes | - |
PSMD3 | 5709 | 57 | 0.986 | 1.106 | 146 | Yes | - |
RPS11 | 6205 | 36 | 0.993 | 1.113 | 175 | Yes | - |
CLTC | 1213 | 35 | 0.884 | 1.138 | 247 | Yes | - |
RPL14 | 9045 | 42 | 1.250 | 1.113 | 143 | Yes | - |
PSMB2 | 5690 | 18 | 0.877 | 1.026 | 117 | Yes | - |
ACTB | 60 | 167 | 1.153 | 1.151 | 587 | Yes | - |
PSMD11 | 5717 | 121 | 1.095 | 1.106 | 183 | Yes | - |
HSPD1 | 3329 | 35 | 0.913 | 1.035 | 286 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
PSMD3 | 5709 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
ACTB | 60 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
RPSA | 3921 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
ACTB | 60 | ATP6V1B2 | 526 | pp | -- | int.I2D: BioGrid_Yeast |
ATP6V1B2 | 526 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
ATP6V1B2 | 526 | CDC16 | 8881 | pp | -- | int.I2D: IntAct_Yeast |
PSMB7 | 5695 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
ATP6V1B2 | 526 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | PSMA1 | 5682 | pp | -- | int.I2D: BioGrid_Yeast |
HSPD1 | 3329 | RPSA | 3921 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPS11 | 6205 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA1 | 5682 | PSMB2 | 5690 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: HPRD, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastHigh; int.HPRD: yeast 2-hybrid |
ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | TNF | 7124 | pp | -- | int.I2D: IntAct_Rat |
PSMA1 | 5682 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
RPL8 | 6132 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
RPSA | 3921 | PSMD11 | 5717 | pp | -- | int.I2D: IntAct_Yeast |
PSMA1 | 5682 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
PSMA1 | 5682 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Mouse, IntAct_Yeast, YeastLow, Krogan_Core, MINT_Yeast |
ACTB | 60 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | RPL8 | 6132 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastLow, IntAct |
ACTB | 60 | CDC16 | 8881 | pp | -- | int.I2D: YeastLow |
PSMB2 | 5690 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
RPL8 | 6132 | TNF | 7124 | pp | -- | int.I2D: IntAct_Rat |
EEF2 | 1938 | HSPD1 | 3329 | pp | -- | int.I2D: YeastLow, YeastMedium |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | EEF2 | 1938 | pp | -- | int.I2D: YeastLow, IntAct_Yeast |
RPL8 | 6132 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
EEF2 | 1938 | PSMD3 | 5709 | pp | -- | int.I2D: Krogan_NonCore |
ACTB | 60 | HSPD1 | 3329 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastLow |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0016071 | mRNA metabolic process | 1.85e-12 | 2.67e-08 | 5.015 | 9 | 31 | 223 |
GO:0016032 | viral process | 4.07e-12 | 5.87e-08 | 4.045 | 11 | 55 | 534 |
GO:0016070 | RNA metabolic process | 4.66e-12 | 6.72e-08 | 4.868 | 9 | 32 | 247 |
GO:0005829 | cytosol | 6.68e-11 | 9.64e-07 | 2.361 | 16 | 132 | 2496 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.18e-10 | 1.70e-06 | 6.209 | 6 | 22 | 65 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.86e-10 | 2.69e-06 | 6.102 | 6 | 22 | 70 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.62e-10 | 3.78e-06 | 6.022 | 6 | 22 | 74 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.92e-10 | 5.66e-06 | 5.927 | 6 | 23 | 79 |
GO:0010467 | gene expression | 1.35e-09 | 1.94e-05 | 3.582 | 10 | 59 | 669 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.38e-09 | 4.87e-05 | 6.324 | 5 | 17 | 50 |
GO:0000502 | proteasome complex | 7.26e-09 | 1.05e-04 | 6.110 | 5 | 17 | 58 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.20e-08 | 1.73e-04 | 5.968 | 5 | 19 | 64 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.84e-08 | 2.66e-04 | 5.012 | 6 | 32 | 149 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.19e-08 | 3.16e-04 | 5.798 | 5 | 20 | 72 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.70e-08 | 3.89e-04 | 5.739 | 5 | 20 | 75 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 7.59e-08 | 1.10e-03 | 5.445 | 5 | 21 | 92 |
GO:0006414 | translational elongation | 8.02e-08 | 1.16e-03 | 5.429 | 5 | 13 | 93 |
GO:0000209 | protein polyubiquitination | 2.43e-07 | 3.51e-03 | 5.110 | 5 | 20 | 116 |
GO:0000278 | mitotic cell cycle | 2.51e-07 | 3.62e-03 | 3.842 | 7 | 48 | 391 |
GO:0070062 | extracellular vesicular exosome | 2.72e-07 | 3.92e-03 | 2.118 | 13 | 104 | 2400 |
GO:0016020 | membrane | 7.61e-07 | 1.10e-02 | 2.390 | 11 | 90 | 1681 |
GO:0042981 | regulation of apoptotic process | 8.74e-07 | 1.26e-02 | 4.739 | 5 | 24 | 150 |
GO:0005839 | proteasome core complex | 1.32e-06 | 1.90e-02 | 7.061 | 3 | 8 | 18 |
GO:0004298 | threonine-type endopeptidase activity | 1.56e-06 | 2.25e-02 | 6.983 | 3 | 8 | 19 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.67e-06 | 2.41e-02 | 4.550 | 5 | 20 | 171 |
GO:0005654 | nucleoplasm | 1.90e-06 | 2.75e-02 | 2.737 | 9 | 76 | 1082 |
GO:0019083 | viral transcription | 2.66e-06 | 3.84e-02 | 5.306 | 4 | 10 | 81 |
GO:0006415 | translational termination | 3.54e-06 | 5.11e-02 | 5.203 | 4 | 10 | 87 |
GO:0006412 | translation | 7.14e-06 | 1.03e-01 | 4.123 | 5 | 20 | 230 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.22e-06 | 1.04e-01 | 4.946 | 4 | 10 | 104 |
GO:0043066 | negative regulation of apoptotic process | 8.57e-06 | 1.24e-01 | 3.503 | 6 | 31 | 424 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.04e-05 | 1.50e-01 | 4.813 | 4 | 11 | 114 |
GO:0019058 | viral life cycle | 1.08e-05 | 1.55e-01 | 4.801 | 4 | 13 | 115 |
GO:0044267 | cellular protein metabolic process | 1.62e-05 | 2.33e-01 | 3.342 | 6 | 29 | 474 |
GO:0006413 | translational initiation | 1.80e-05 | 2.60e-01 | 4.613 | 4 | 17 | 131 |
GO:0003735 | structural constituent of ribosome | 2.15e-05 | 3.10e-01 | 4.548 | 4 | 10 | 137 |
GO:0006915 | apoptotic process | 3.95e-05 | 5.70e-01 | 3.115 | 6 | 33 | 555 |
GO:0005838 | proteasome regulatory particle | 9.64e-05 | 1.00e+00 | 7.061 | 2 | 7 | 12 |
GO:0044822 | poly(A) RNA binding | 1.72e-04 | 1.00e+00 | 2.409 | 7 | 49 | 1056 |
GO:0022624 | proteasome accessory complex | 1.98e-04 | 1.00e+00 | 6.559 | 2 | 8 | 17 |
GO:0005844 | polysome | 3.66e-04 | 1.00e+00 | 6.123 | 2 | 4 | 23 |
GO:0005515 | protein binding | 3.76e-04 | 1.00e+00 | 0.997 | 15 | 184 | 6024 |
GO:0019843 | rRNA binding | 5.07e-04 | 1.00e+00 | 5.891 | 2 | 3 | 27 |
GO:0033572 | transferrin transport | 6.27e-04 | 1.00e+00 | 5.739 | 2 | 5 | 30 |
GO:0032755 | positive regulation of interleukin-6 production | 9.04e-04 | 1.00e+00 | 5.476 | 2 | 2 | 36 |
GO:0005925 | focal adhesion | 9.41e-04 | 1.00e+00 | 3.130 | 4 | 19 | 366 |
GO:0032729 | positive regulation of interferon-gamma production | 1.06e-03 | 1.00e+00 | 5.361 | 2 | 2 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 1.06e-03 | 1.00e+00 | 5.361 | 2 | 4 | 39 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0002037 | negative regulation of L-glutamate transport | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0045994 | positive regulation of translational initiation by iron | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 1 |
GO:0022625 | cytosolic large ribosomal subunit | 1.67e-03 | 1.00e+00 | 5.031 | 2 | 6 | 49 |
GO:0003725 | double-stranded RNA binding | 1.88e-03 | 1.00e+00 | 4.946 | 2 | 5 | 52 |
GO:0006407 | rRNA export from nucleus | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:1990268 | response to gold nanoparticle | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 2 |
GO:0003697 | single-stranded DNA binding | 3.19e-03 | 1.00e+00 | 4.559 | 2 | 5 | 68 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0043243 | positive regulation of protein complex disassembly | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0032800 | receptor biosynthetic process | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 2 | 3 |
GO:0006458 | 'de novo' protein folding | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0071677 | positive regulation of mononuclear cell migration | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0071439 | clathrin complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 2 | 3 |
GO:0032741 | positive regulation of interleukin-18 production | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0030730 | sequestering of triglyceride | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 3 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 4.07e-03 | 1.00e+00 | 4.379 | 2 | 7 | 77 |
GO:0010693 | negative regulation of alkaline phosphatase activity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0032051 | clathrin light chain binding | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0043242 | negative regulation of protein complex disassembly | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0051222 | positive regulation of protein transport | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0051798 | positive regulation of hair follicle development | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 4 |
GO:0043234 | protein complex | 5.50e-03 | 1.00e+00 | 3.027 | 3 | 18 | 295 |
GO:0042470 | melanosome | 5.64e-03 | 1.00e+00 | 4.138 | 2 | 9 | 91 |
GO:0001649 | osteoblast differentiation | 5.76e-03 | 1.00e+00 | 4.123 | 2 | 6 | 92 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 3 | 5 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0031622 | positive regulation of fever generation | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 2 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0051023 | regulation of immunoglobulin secretion | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 2 | 5 |
GO:0071803 | positive regulation of podosome assembly | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 1 | 5 |
GO:0019901 | protein kinase binding | 6.72e-03 | 1.00e+00 | 2.923 | 3 | 21 | 317 |
GO:0003688 | DNA replication origin binding | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 2 | 6 |
GO:0097527 | necroptotic signaling pathway | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 6 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 3 | 6 |
GO:0030118 | clathrin coat | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 2 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 3 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 6 |
GO:0006927 | transformed cell apoptotic process | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 6 |
GO:2000010 | positive regulation of protein localization to cell surface | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 2 | 6 |
GO:0003723 | RNA binding | 8.28e-03 | 1.00e+00 | 2.813 | 3 | 20 | 342 |
GO:0030529 | ribonucleoprotein complex | 8.43e-03 | 1.00e+00 | 3.839 | 2 | 8 | 112 |
GO:0005819 | spindle | 8.43e-03 | 1.00e+00 | 3.839 | 2 | 7 | 112 |
GO:0000028 | ribosomal small subunit assembly | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0045760 | positive regulation of action potential | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0010888 | negative regulation of lipid storage | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 7 |
GO:0046325 | negative regulation of glucose import | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0033180 | proton-transporting V-type ATPase, V1 domain | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 7 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0030132 | clathrin coat of coated pit | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 7 |
GO:0001775 | cell activation | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 7 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 8 |
GO:0071316 | cellular response to nicotine | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 8 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 4 | 8 |
GO:0043068 | positive regulation of programmed cell death | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0051604 | protein maturation | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 8 |
GO:0008494 | translation activator activity | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 9 |
GO:0000185 | activation of MAPKKK activity | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 2 | 9 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 9 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 10 |
GO:0043032 | positive regulation of macrophage activation | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 10 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 11 |
GO:0032727 | positive regulation of interferon-alpha production | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 4 | 11 |
GO:0061024 | membrane organization | 1.38e-02 | 1.00e+00 | 3.466 | 2 | 7 | 145 |
GO:0010628 | positive regulation of gene expression | 1.40e-02 | 1.00e+00 | 3.456 | 2 | 5 | 146 |
GO:0044281 | small molecule metabolic process | 1.41e-02 | 1.00e+00 | 1.726 | 5 | 58 | 1211 |
GO:0050806 | positive regulation of synaptic transmission | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 12 |
GO:0042273 | ribosomal large subunit biogenesis | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 4 | 13 |
GO:0050995 | negative regulation of lipid catabolic process | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 13 |
GO:0005662 | DNA replication factor A complex | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 13 |
GO:0031334 | positive regulation of protein complex assembly | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 13 |
GO:0030234 | enzyme regulator activity | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 3 | 13 |
GO:0001530 | lipopolysaccharide binding | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 3 | 13 |
GO:0001891 | phagocytic cup | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 4 | 14 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 14 |
GO:0048566 | embryonic digestive tract development | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 14 |
GO:0009651 | response to salt stress | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 14 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 14 |
GO:0050901 | leukocyte tethering or rolling | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 1 | 15 |
GO:0042026 | protein refolding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 15 |
GO:0046034 | ATP metabolic process | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 1 | 15 |
GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 3 | 15 |
GO:0042176 | regulation of protein catabolic process | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 16 |
GO:0032722 | positive regulation of chemokine production | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 16 |
GO:0050998 | nitric-oxide synthase binding | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 16 |
GO:0031625 | ubiquitin protein ligase binding | 2.04e-02 | 1.00e+00 | 3.170 | 2 | 14 | 178 |
GO:0010243 | response to organonitrogen compound | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 3 | 17 |
GO:0001819 | positive regulation of cytokine production | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 17 |
GO:0003746 | translation elongation factor activity | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 3 | 17 |
GO:0003009 | skeletal muscle contraction | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 17 |
GO:0050870 | positive regulation of T cell activation | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 17 |
GO:0044130 | negative regulation of growth of symbiont in host | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 17 |
GO:0035861 | site of double-strand break | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 18 |
GO:0007088 | regulation of mitosis | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 18 |
GO:0045672 | positive regulation of osteoclast differentiation | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 18 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 2 | 18 |
GO:0015078 | hydrogen ion transmembrane transporter activity | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 3 | 19 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 1 | 19 |
GO:0032733 | positive regulation of interleukin-10 production | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 1 | 19 |
GO:0005680 | anaphase-promoting complex | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 4 | 20 |
GO:0032715 | negative regulation of interleukin-6 production | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 20 |
GO:0006298 | mismatch repair | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 3 | 20 |
GO:0042100 | B cell proliferation | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 1 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 4 | 21 |
GO:0032201 | telomere maintenance via semi-conservative replication | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 5 | 21 |
GO:0030316 | osteoclast differentiation | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 22 |
GO:0050715 | positive regulation of cytokine secretion | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 22 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 3 | 22 |
GO:0030863 | cortical cytoskeleton | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 4 | 22 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 1 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 4 | 23 |
GO:0000060 | protein import into nucleus, translocation | 2.95e-02 | 1.00e+00 | 5.061 | 1 | 5 | 24 |
GO:0000722 | telomere maintenance via recombination | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 5 | 25 |
GO:0042113 | B cell activation | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 1 | 25 |
GO:0070979 | protein K11-linked ubiquitination | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 6 | 26 |
GO:0007067 | mitotic nuclear division | 3.20e-02 | 1.00e+00 | 2.820 | 2 | 14 | 227 |
GO:0015991 | ATP hydrolysis coupled proton transport | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 4 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 3 | 26 |
GO:0043022 | ribosome binding | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 3 | 27 |
GO:0009314 | response to radiation | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 27 |
GO:0031492 | nucleosomal DNA binding | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 4 | 27 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 28 |
GO:0045840 | positive regulation of mitosis | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 28 |
GO:0043507 | positive regulation of JUN kinase activity | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 28 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 4 | 28 |
GO:0019894 | kinesin binding | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 1 | 28 |
GO:0019005 | SCF ubiquitin ligase complex | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 1 | 29 |
GO:0015992 | proton transport | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 3 | 29 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 2 | 29 |
GO:0006271 | DNA strand elongation involved in DNA replication | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 7 | 30 |
GO:0005164 | tumor necrosis factor receptor binding | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 30 |
GO:0014823 | response to activity | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 1 | 31 |
GO:0031623 | receptor internalization | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 2 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 4 | 31 |
GO:0043491 | protein kinase B signaling | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 2 | 32 |
GO:0051701 | interaction with host | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 4 | 32 |
GO:0006281 | DNA repair | 4.13e-02 | 1.00e+00 | 2.618 | 2 | 18 | 261 |
GO:0032588 | trans-Golgi network membrane | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 2 | 34 |
GO:0001895 | retina homeostasis | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 1 | 34 |
GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 2 | 34 |
GO:2001240 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 2 | 34 |
GO:0045071 | negative regulation of viral genome replication | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 1 | 34 |
GO:0005876 | spindle microtubule | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 2 | 34 |
GO:0045599 | negative regulation of fat cell differentiation | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 2 | 35 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 3 | 35 |
GO:0043065 | positive regulation of apoptotic process | 4.33e-02 | 1.00e+00 | 2.580 | 2 | 10 | 268 |
GO:0034332 | adherens junction organization | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 1 | 36 |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 1 | 36 |
GO:0045668 | negative regulation of osteoblast differentiation | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 1 | 36 |
GO:0090382 | phagosome maturation | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 5 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.52e-02 | 1.00e+00 | 4.437 | 1 | 4 | 37 |
GO:0006284 | base-excision repair | 4.52e-02 | 1.00e+00 | 4.437 | 1 | 3 | 37 |
GO:0005730 | nucleolus | 4.58e-02 | 1.00e+00 | 1.288 | 5 | 69 | 1641 |
GO:0005902 | microvillus | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 2 | 38 |
GO:0097191 | extrinsic apoptotic signaling pathway | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 3 | 38 |
GO:0071407 | cellular response to organic cyclic compound | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 2 | 38 |
GO:0000781 | chromosome, telomeric region | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 3 | 39 |
GO:0019722 | calcium-mediated signaling | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 1 | 39 |
GO:0042110 | T cell activation | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 3 | 42 |
GO:0030136 | clathrin-coated vesicle | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 4 | 42 |
GO:0071230 | cellular response to amino acid stimulus | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 3 | 42 |
GO:0006892 | post-Golgi vesicle-mediated transport | 5.24e-02 | 1.00e+00 | 4.220 | 1 | 3 | 43 |
GO:0014070 | response to organic cyclic compound | 5.24e-02 | 1.00e+00 | 4.220 | 1 | 4 | 43 |
GO:0021762 | substantia nigra development | 5.35e-02 | 1.00e+00 | 4.187 | 1 | 2 | 44 |
GO:0045727 | positive regulation of translation | 5.35e-02 | 1.00e+00 | 4.187 | 1 | 3 | 44 |
GO:0050830 | defense response to Gram-positive bacterium | 5.47e-02 | 1.00e+00 | 4.154 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 5.59e-02 | 1.00e+00 | 4.123 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.59e-02 | 1.00e+00 | 4.123 | 1 | 7 | 46 |
GO:0043406 | positive regulation of MAP kinase activity | 5.59e-02 | 1.00e+00 | 4.123 | 1 | 4 | 46 |
GO:0006959 | humoral immune response | 5.71e-02 | 1.00e+00 | 4.092 | 1 | 1 | 47 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 5.95e-02 | 1.00e+00 | 4.031 | 1 | 5 | 49 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 5.95e-02 | 1.00e+00 | 4.031 | 1 | 4 | 49 |
GO:0007254 | JNK cascade | 5.95e-02 | 1.00e+00 | 4.031 | 1 | 3 | 49 |
GO:0003684 | damaged DNA binding | 5.95e-02 | 1.00e+00 | 4.031 | 1 | 7 | 49 |
GO:0006986 | response to unfolded protein | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 2 | 50 |
GO:0005905 | coated pit | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 3 | 50 |
GO:0005813 | centrosome | 6.14e-02 | 1.00e+00 | 2.297 | 2 | 14 | 326 |
GO:0006879 | cellular iron ion homeostasis | 6.18e-02 | 1.00e+00 | 3.974 | 1 | 4 | 51 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 2 | 54 |
GO:0002244 | hematopoietic progenitor cell differentiation | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 54 |
GO:0002039 | p53 binding | 6.65e-02 | 1.00e+00 | 3.865 | 1 | 7 | 55 |
GO:0000724 | double-strand break repair via homologous recombination | 6.65e-02 | 1.00e+00 | 3.865 | 1 | 3 | 55 |
GO:0000723 | telomere maintenance | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 6 | 56 |
GO:0012505 | endomembrane system | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 2 | 56 |
GO:0005840 | ribosome | 7.00e-02 | 1.00e+00 | 3.788 | 1 | 1 | 58 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 7.12e-02 | 1.00e+00 | 3.764 | 1 | 2 | 59 |
GO:0051087 | chaperone binding | 7.12e-02 | 1.00e+00 | 3.764 | 1 | 6 | 59 |
GO:0006302 | double-strand break repair | 7.47e-02 | 1.00e+00 | 3.692 | 1 | 4 | 62 |
GO:0019903 | protein phosphatase binding | 7.47e-02 | 1.00e+00 | 3.692 | 1 | 4 | 62 |
GO:0051384 | response to glucocorticoid | 7.47e-02 | 1.00e+00 | 3.692 | 1 | 2 | 62 |
GO:0030141 | secretory granule | 7.47e-02 | 1.00e+00 | 3.692 | 1 | 2 | 62 |
GO:0006289 | nucleotide-excision repair | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 11 | 68 |
GO:0034329 | cell junction assembly | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 1 | 68 |
GO:0055037 | recycling endosome | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 2 | 70 |
GO:0051897 | positive regulation of protein kinase B signaling | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 1 | 70 |
GO:0000165 | MAPK cascade | 8.62e-02 | 1.00e+00 | 3.476 | 1 | 2 | 72 |
GO:0009986 | cell surface | 8.84e-02 | 1.00e+00 | 1.995 | 2 | 11 | 402 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 8.85e-02 | 1.00e+00 | 3.437 | 1 | 6 | 74 |
GO:0002020 | protease binding | 8.85e-02 | 1.00e+00 | 3.437 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 8.96e-02 | 1.00e+00 | 3.417 | 1 | 2 | 75 |
GO:0010629 | negative regulation of gene expression | 9.19e-02 | 1.00e+00 | 3.379 | 1 | 1 | 77 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 9.53e-02 | 1.00e+00 | 3.324 | 1 | 3 | 80 |
GO:0001726 | ruffle | 9.53e-02 | 1.00e+00 | 3.324 | 1 | 4 | 80 |
GO:0050796 | regulation of insulin secretion | 9.65e-02 | 1.00e+00 | 3.306 | 1 | 4 | 81 |
GO:0006898 | receptor-mediated endocytosis | 9.99e-02 | 1.00e+00 | 3.254 | 1 | 3 | 84 |
GO:0047485 | protein N-terminus binding | 1.02e-01 | 1.00e+00 | 3.220 | 1 | 5 | 86 |
GO:0009887 | organ morphogenesis | 1.02e-01 | 1.00e+00 | 3.220 | 1 | 2 | 86 |
GO:0050821 | protein stabilization | 1.04e-01 | 1.00e+00 | 3.187 | 1 | 2 | 88 |
GO:0016605 | PML body | 1.04e-01 | 1.00e+00 | 3.187 | 1 | 3 | 88 |
GO:0000187 | activation of MAPK activity | 1.07e-01 | 1.00e+00 | 3.154 | 1 | 5 | 90 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.07e-01 | 1.00e+00 | 3.154 | 1 | 7 | 90 |
GO:0006928 | cellular component movement | 1.08e-01 | 1.00e+00 | 3.138 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 1.08e-01 | 1.00e+00 | 3.138 | 1 | 8 | 91 |
GO:0071456 | cellular response to hypoxia | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 6 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 5 | 92 |
GO:0051082 | unfolded protein binding | 1.10e-01 | 1.00e+00 | 3.107 | 1 | 5 | 93 |
GO:0006364 | rRNA processing | 1.11e-01 | 1.00e+00 | 3.092 | 1 | 6 | 94 |
GO:0005615 | extracellular space | 1.13e-01 | 1.00e+00 | 1.329 | 3 | 17 | 957 |
GO:0001934 | positive regulation of protein phosphorylation | 1.22e-01 | 1.00e+00 | 2.946 | 1 | 6 | 104 |
GO:0014069 | postsynaptic density | 1.23e-01 | 1.00e+00 | 2.932 | 1 | 3 | 105 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 2 | 106 |
GO:0015630 | microtubule cytoskeleton | 1.29e-01 | 1.00e+00 | 2.865 | 1 | 4 | 110 |
GO:0072562 | blood microparticle | 1.30e-01 | 1.00e+00 | 2.852 | 1 | 3 | 111 |
GO:0097190 | apoptotic signaling pathway | 1.32e-01 | 1.00e+00 | 2.826 | 1 | 6 | 113 |
GO:0006006 | glucose metabolic process | 1.38e-01 | 1.00e+00 | 2.764 | 1 | 7 | 118 |
GO:0006325 | chromatin organization | 1.38e-01 | 1.00e+00 | 2.764 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 1.40e-01 | 1.00e+00 | 2.739 | 1 | 5 | 120 |
GO:0006260 | DNA replication | 1.41e-01 | 1.00e+00 | 2.727 | 1 | 9 | 121 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.44e-01 | 1.00e+00 | 2.692 | 1 | 4 | 124 |
GO:0009615 | response to virus | 1.46e-01 | 1.00e+00 | 2.669 | 1 | 5 | 126 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.46e-01 | 1.00e+00 | 2.669 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 1.49e-01 | 1.00e+00 | 2.635 | 1 | 9 | 129 |
GO:0031982 | vesicle | 1.52e-01 | 1.00e+00 | 2.613 | 1 | 9 | 131 |
GO:0005125 | cytokine activity | 1.59e-01 | 1.00e+00 | 2.538 | 1 | 1 | 138 |
GO:0016887 | ATPase activity | 1.61e-01 | 1.00e+00 | 2.517 | 1 | 7 | 140 |
GO:0008286 | insulin receptor signaling pathway | 1.63e-01 | 1.00e+00 | 2.496 | 1 | 7 | 142 |
GO:0006457 | protein folding | 1.64e-01 | 1.00e+00 | 2.486 | 1 | 7 | 143 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.66e-01 | 1.00e+00 | 2.466 | 1 | 4 | 145 |
GO:0001666 | response to hypoxia | 1.71e-01 | 1.00e+00 | 2.427 | 1 | 5 | 149 |
GO:0005198 | structural molecule activity | 1.72e-01 | 1.00e+00 | 2.417 | 1 | 5 | 150 |
GO:0005769 | early endosome | 1.74e-01 | 1.00e+00 | 2.398 | 1 | 2 | 152 |
GO:0045121 | membrane raft | 1.78e-01 | 1.00e+00 | 2.361 | 1 | 8 | 156 |
GO:0005634 | nucleus | 1.78e-01 | 1.00e+00 | 0.492 | 8 | 136 | 4559 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.87e-01 | 1.00e+00 | 2.280 | 1 | 7 | 165 |
GO:0030424 | axon | 1.88e-01 | 1.00e+00 | 2.271 | 1 | 4 | 166 |
GO:0044212 | transcription regulatory region DNA binding | 1.90e-01 | 1.00e+00 | 2.254 | 1 | 6 | 168 |
GO:0006886 | intracellular protein transport | 1.93e-01 | 1.00e+00 | 2.228 | 1 | 5 | 171 |
GO:0009897 | external side of plasma membrane | 1.99e-01 | 1.00e+00 | 2.179 | 1 | 3 | 177 |
GO:0032403 | protein complex binding | 2.05e-01 | 1.00e+00 | 2.130 | 1 | 10 | 183 |
GO:0005886 | plasma membrane | 2.08e-01 | 1.00e+00 | 0.634 | 5 | 45 | 2582 |
GO:0005524 | ATP binding | 2.17e-01 | 1.00e+00 | 0.889 | 3 | 60 | 1298 |
GO:0003924 | GTPase activity | 2.19e-01 | 1.00e+00 | 2.024 | 1 | 12 | 197 |
GO:0005765 | lysosomal membrane | 2.25e-01 | 1.00e+00 | 1.981 | 1 | 5 | 203 |
GO:0006184 | GTP catabolic process | 2.36e-01 | 1.00e+00 | 1.905 | 1 | 12 | 214 |
GO:0005759 | mitochondrial matrix | 2.49e-01 | 1.00e+00 | 1.813 | 1 | 14 | 228 |
GO:0004842 | ubiquitin-protein transferase activity | 2.75e-01 | 1.00e+00 | 1.652 | 1 | 6 | 255 |
GO:0005743 | mitochondrial inner membrane | 2.95e-01 | 1.00e+00 | 1.532 | 1 | 8 | 277 |
GO:0006954 | inflammatory response | 2.95e-01 | 1.00e+00 | 1.532 | 1 | 7 | 277 |
GO:0019899 | enzyme binding | 2.95e-01 | 1.00e+00 | 1.532 | 1 | 12 | 277 |
GO:0030198 | extracellular matrix organization | 3.00e-01 | 1.00e+00 | 1.502 | 1 | 4 | 283 |
GO:0042493 | response to drug | 3.01e-01 | 1.00e+00 | 1.496 | 1 | 13 | 284 |
GO:0005856 | cytoskeleton | 3.07e-01 | 1.00e+00 | 1.461 | 1 | 12 | 291 |
GO:0006200 | ATP catabolic process | 3.08e-01 | 1.00e+00 | 1.456 | 1 | 15 | 292 |
GO:0016567 | protein ubiquitination | 3.11e-01 | 1.00e+00 | 1.442 | 1 | 5 | 295 |
GO:0005737 | cytoplasm | 3.22e-01 | 1.00e+00 | 0.352 | 6 | 110 | 3767 |
GO:0005525 | GTP binding | 3.24e-01 | 1.00e+00 | 1.370 | 1 | 12 | 310 |
GO:0043231 | intracellular membrane-bounded organelle | 3.31e-01 | 1.00e+00 | 1.333 | 1 | 9 | 318 |
GO:0007411 | axon guidance | 3.32e-01 | 1.00e+00 | 1.329 | 1 | 13 | 319 |
GO:0008283 | cell proliferation | 3.39e-01 | 1.00e+00 | 1.289 | 1 | 14 | 328 |
GO:0008285 | negative regulation of cell proliferation | 3.60e-01 | 1.00e+00 | 1.183 | 1 | 11 | 353 |
GO:0007155 | cell adhesion | 3.73e-01 | 1.00e+00 | 1.119 | 1 | 6 | 369 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.07e-01 | 1.00e+00 | 0.956 | 1 | 15 | 413 |
GO:0055085 | transmembrane transport | 4.24e-01 | 1.00e+00 | 0.881 | 1 | 10 | 435 |
GO:0007596 | blood coagulation | 4.39e-01 | 1.00e+00 | 0.816 | 1 | 18 | 455 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.55e-01 | 1.00e+00 | 0.745 | 1 | 13 | 478 |
GO:0042802 | identical protein binding | 4.59e-01 | 1.00e+00 | 0.727 | 1 | 20 | 484 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.16e-01 | 1.00e+00 | 0.491 | 1 | 16 | 570 |
GO:0045087 | innate immune response | 5.32e-01 | 1.00e+00 | 0.427 | 1 | 24 | 596 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.37e-01 | 1.00e+00 | 0.022 | 1 | 19 | 789 |
GO:0005887 | integral component of plasma membrane | 6.82e-01 | 1.00e+00 | -0.148 | 1 | 6 | 888 |
GO:0005576 | extracellular region | 7.04e-01 | 1.00e+00 | -0.233 | 1 | 4 | 942 |
GO:0008270 | zinc ion binding | 7.25e-01 | 1.00e+00 | -0.315 | 1 | 12 | 997 |
GO:0005739 | mitochondrion | 7.25e-01 | 1.00e+00 | -0.317 | 1 | 28 | 998 |
GO:0016021 | integral component of membrane | 9.30e-01 | 1.00e+00 | -1.307 | 1 | 27 | 1982 |